type 2 diabetes and semaglutide MDedge - Patients with #diabetes treated with achieve reductions in HbA1c levels weight. https://www.mdedge.com/endocrinology/article/211101/diabetes /sustain-10-glycemic-control-weight-loss-better-semaglutide Diabetes Risk Can be Curtailed

PubMed Fras JP, Davies MJ, Rosenstock J, Prez Manghi FC, Fernndez Land L, Bergman BK, et al

Starting at Week 12 and through Week 72, there was a trend of greater reductions from baseline in average ALT and AST in the WEGOVY injection group as compared to the placebo group

Substance P stimulates CFTR-dependent fluid secretion by mouse tracheal submucosal glands

miRNA-345-5p, which is upregulated in steatotic cells, targets hypoxia-inducible factor-1 alpha (HIF-1) and suppresses its expression and subsequent TGF/Smad signaling

Patients taking blood thinners should apply pressure for longer to minimize bruising risk

"So, that became a go-to medication." Ozempic (FOX 5) Then, in 2021, the FDA approved Wegovy, another brand name injectable made by the same company, Novo Nordisk, as a weight loss drug